Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Piper Sandler Downgrades Moderna to Neutral, Raises Price Target to $445

Piper Sandler analyst Edward Tenthoff downgrades Moderna (NASDAQ:MRNA) from Overweight to Neutral and raises the price target from $246 to $445.
byBenzinga Newsdesk
August 6, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Piper Sandler analyst Edward Tenthoff downgrades Moderna (NASDAQ:MRNA) from Overweight to Neutral and raises the price target from $246 to $445.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts